2025-08-08 20:34:39
Latest Post
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
RBI grants NBFC license to Equirus Group
Stock Report
Simran Farms posts consolidated loss at Rs. 2.51 crore in Q3FY22
Posted On : 2022-02-16 14:49:13( TIMEZONE : IST )
SIMRAN FARMS LTD. has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 106.1067 crores during the period ended December 31, 2021 as compared to Rs. 112.4871 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -2.5128 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 3.1417 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -6.66 for the period ended December 31, 2021 as compared to Rs. 8.25 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 106.1067 crs | ₹112.4871 crs |  -5.67% |
| Net Profit | ₹-2.5128 crs | ₹3.1417 crs | -179.98% |
| EPS | ₹-6.66 | ₹8.25 | -180.73% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 106.1067 crores during the period ended December 31, 2021 as compared to Rs.111.7720 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-2.5128 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.8.8751 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-6.66 for the period ended December 31, 2021 as compared to Rs.23.37 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 106.1067 crs | ₹111.7720 crs | -5.07% |
| Net Profit | ₹-2.5128 crs | ₹8.8751 crs | -128.31% |
| EPS | ₹-6.66 | ₹23.37 | -128.50% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.308.8913 crores during the 9 Months period ended December 31, 2021 as compared to Rs.251.8797 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.6.3963 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.18.6156 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.16.76 for the 9 Months period ended December 31, 2021 as compared to Rs.49.03 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹308.8913 crs | ₹251.8797 crs |  22.63% |
| Net Profit | ₹6.3963 crs | ₹18.6156 crs | -65.64% |
| EPS | ₹16.76 | ₹49.03 | -65.82% |
Shares of SIMRAN FARMS LTD. was last trading in BSE at Rs. 189.85 as compared to the previous close of Rs. 199.80. The total number of shares traded during the day was 14910 in over 194 trades.
The stock hit an intraday high of Rs. 189.85 and intraday low of 189.85. The net turnover during the day was Rs. 2830663.00.
